Literature DB >> 3384938

Serratia odorifera biogroup 1 causing an invasive human infection.

H Chmel1.   

Abstract

Serratia odorifera biogroup 1 was isolated from the blood and urine of an alcoholic male with cirrhosis and signs of septic shock. The organism is rarely reported to occur in clinical specimens. This is the first case in which the organism was found to be responsible for invasive human infection.

Entities:  

Mesh：

Year:  1988        PMID： 3384938      PMCID： PMC266576          DOI： 10.1128/jcm.26.6.1244-1245.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  3 in total

1.  Host factors causing increased susceptibility to infection in patients with Laennec's cirrhosis.

Authors:  B R Andersen
Journal:  Ann N Y Acad Sci       Date:  1975-04-25       Impact factor: 5.691

Review 2.  Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens.

Authors:  J J Farmer; B R Davis; F W Hickman-Brenner; A McWhorter; G P Huntley-Carter; M A Asbury; C Riddle; H G Wathen-Grady; C Elias; G R Fanning
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

3.  Serratia plymuthica sepsis associated with infection of central venous catheter.

Authors:  H W Horowitz; R B Nadelman; K G Van Horn; S E Weekes; L Goyburu; G P Wormser
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948
  3 in total
  6 in total

1.  Serratia rubidaea as an invasive pathogen.

Authors:  P R Ursua; M J Unzaga; P Melero; I Iturburu; C Ezpeleta; R Cisterna
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

2.  Catheter-associated sepsis caused by Serratia odorifera biovar 1 in an adolescent patient.

Authors:  J Z Glustein; B Rudensky; A Abrahamov
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-02       Impact factor: 3.267

3.  In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.

Authors:  P Hohl; J Lüthy-Hottenstein; J Zollinger-Iten; M Altwegg
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 4.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

5.  Intestinal Bacterial Communities of Trypanosome-Infected and Uninfected Glossina palpalis palpalis from Three Human African Trypanomiasis Foci in Cameroon.

Authors:  Franck Jacob; Trésor T Melachio; Guy R Njitchouang; Geoffrey Gimonneau; Flobert Njiokou; Luc Abate; Richard Christen; Julie Reveillaud; Anne Geiger
Journal:  Front Microbiol       Date:  2017-08-03       Impact factor: 5.640

Review 6.  Serratia Liver Abscess Infection and Cardiomyopathy in a Patient with Diabetes Mellitus: A Case Report and Review of the Literature.

Authors:  Anna Sarah Erem; Anna Krapivina; Timothy S Braverman; Shyam S Allamaneni
Journal:  Am J Case Rep       Date:  2019-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.